Lipid Control After Percutaneous Coronary Intervention (PCI) in China

clinical lipid control success rate before and after percutaneous coronary intervention in iran; a single center study

conclusions although by current treatments, the prevalence of patients with low tc, ldl-c and non-hdl-c has significantly increased; dyslipidemia persisted in a considerable proportion of patients. these results necessitate further investigations into the relationship between high serum lipids and long-term outcome of patients after pci as well as further evaluations of the dyslipidemia treatme...

Individualising dual antiplatelet therapy after percutaneous coronary intervention: the IDEAL-PCI registry

OBJECTIVE To evaluate the clinical utility of individualising dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) in an all-comers population, including ST-elevation myocardial infarction (STEMI) patients. SETTING Tertiary care single centre registry. PARTICIPANTS 1008 consecutive PCI patients with stent implantation, without exclusion criteria. INTERVENTION Pe...

The effectiveness of "Siriraj Leg Lock" brace on back pain after percutaneous coronary intervention: PCI.

BACKGROUND The most common problem experienced by patients after Percutaneous Coronary Intervention (PCI) is back pain. After the procedure, patients are restricted to complete bed rest with no hip flexion for up to 10 hours, causing much discomfort, especially back pain. In some patients, anxiety arises due to limited movement, with the belief that movement might cause re-bleeding from the wou...

The sPLA2 Inhibition to Decrease Enzyme Release after Percutaneous Coronary Intervention (SPIDER-PCI) trial.

BACKGROUND Secretory phospholipase A(2) (sPLA(2)) may play a role in myonecrosis after elective percutaneous coronary intervention (PCI). Inhibition of this enzyme may have a beneficial effect. The central hypothesis of this study was that treatment with varespladib, a small-molecule inhibitor of sPLA(2) would reduce postprocedural release of cardiac biomarkers after elective percutaneous coron...

In stent restenosis after percutaneous coronary intervention